Cargando…
Risk Factors of Clonally Related, Multi, and Extensively Drug-Resistant Acinetobacter baumannii in Severely Ill COVID-19 Patients
BACKGROUND: The secondary infection of multi and extensively drug-resistant “Acinetobacter baumannii” in severely ill COVID-19 individuals is usually associated with extended hospitalisation and a high mortality rate. The current study aimed to assess the exact incidence rate of A. baumannii coinfec...
Autores principales: | Ahmed, Meqdad Saleh, Abdulrahman, Zirak Faqe Ahmed, Taha, Zanan Mohammed Ameen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940951/ https://www.ncbi.nlm.nih.gov/pubmed/36814503 http://dx.doi.org/10.1155/2023/3139270 |
Ejemplares similares
-
Extensively Drug-Resistant Acinetobacter baumannii
por: Doi, Yohei, et al.
Publicado: (2009) -
Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
por: Mohammed, Mostafa A., et al.
Publicado: (2020) -
Colonization With Extensively Drug-Resistant Acinetobacter baumannii and Prognosis in Critically Ill Patients: An Observational Cohort Study
por: Zheng, Yue, et al.
Publicado: (2021) -
Biofilm-Formation in Clonally Unrelated Multidrug-Resistant Acinetobacter baumannii Isolates
por: Alamri, Aisha M., et al.
Publicado: (2020) -
Investigations on Acinetophage, QAB 3.4, Targeting Extensively Drug-Resistant Acinetobacter baumannii Isolates
por: Hussain, Aamir, et al.
Publicado: (2021)